IDbyDNA Participates in NIH National COVID-19 Genomics Consortium
The CDC is leading the national SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance initiative (SPHERES) to coordinate SARS-CoV-2 sequencing across the U.S. Utah’s own IDbyDNA will be participating in the effort along with clinical and public health laboratories, academic institutions, and other private sector companies. The SPHERES consortium aims to generate information […]
Silver lining: opportunities can arise from the corona crisis
Author: Anja Petschauer Co-authors: Anna Derschang, Melitta Gilllespie gwSaar has been a member of BioUtah and a trusted partner of the State of Utah for many years. As a German investment promotion agency, we can observe the economic trends developing in our crisis-stricken global economy first-hand. We are honored that BioUtah has asked us to provide […]
BioUtah’s Newest Associate Member: Greg Gunn, Colliers International
BioUtah’s newest Associate Member is Greg Gunn at Colliers International. With over 35 years of experience in commercial real estate, Greg has negotiated over $700 million in leases representing properties anywhere from 1,000 to 145,000 square feet in size. As a Senior Vice President at Colliers International, Greg has been impressed with the growth of […]
AdvaMed Request for Tariff Exclusions for Medical Technology Products
The Advanced Medical Technology Association (AdvaMed) has consistently indicated that the United States should not be imposing tariffs on medical technology. USTR’s moves in that direction are welcome. We are grateful to USTR for its recent decision to grant exclusions for a range of personal protective equipment (PPE) imports from China. This action could help […]
State Legislature Wraps Up Special Sessions
Last week, the Utah State Legislature wrapped up three special sessions in which lawmakers passed a number of bills to respond to the COVID-19 crisis, including measures to expand unemployment benefits and to provide immunity from coronavirus claims for business operators. Another special session will be held, likely in May, to consider adjustments to the […]
PhotoPharmics Gets FDA Breakthrough Status for Parkinson’s PhotoTherapy
PhotoPharmics, a pioneer in specialized phototherapy, announced on April 29, that it has received FDA Breakthrough device designation for the company’s non-invasive Specialized Phototherapy Device. “Hats off to Utah’s PhotoPharmics,” said Kelvyn Cullimore, president and CEO of BioUtah. “Earning this Breakthrough designation is a significant value driver for a privately-owned device company.” “Our device is […]
Sodium Chloride(NaCI)Aerosol Test Final Report
Summary: This procedure was performed to evaluate the particle penetration and air flow resistance properties of filtration materials. A neutralized, poly-dispersed aerosol of sodium chloride(NaCI) was generated and passed through the test article. The performance of the test article was assessed by measuring the concentration of salt particles penetrating the test article compared to the […]
KidneyIntelX™ to predict major adverse kidney events in COVID-19 patients
Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro diagnostics for kidney disease, announces that the KidneyIntelX™ platform will be used by investigators from the Icahn School of Medicine at Mount Sinai to assess the risk of adverse kidney events in patients diagnosed with COVID-19. Acute and chronic kidney disease is strongly associated with severity […]
FDA Grants Breakthrough Designation for Non-Invasive Phototherapy Device in Parkinson’s Disease
PhotoPharmics achieves priority designation for innovative PD therapy April 29, 2020, Salt Lake City, UT— PhotoPharmics, a pioneer in specialized phototherapy, today announced that it has received FDA Breakthrough device designation for the company’s non-invasive Specialized Phototherapy Device. This prescription device is intended as an adjunct therapy for the treatment of Parkinson’s disease. It is […]
Lunch and Learn: What to Know About 409A Valuations
Gregg Hamilton-Piercy, The MFA Companies & Kurt Sheline, Echo Health Ventures, will discuss some of the most common valuation methods. Join Gregg Hamilton-Piercy, CFA, ASA, The MFA Companies, and Kurt Sheline, Echo Health Ventures, for a Lunch and Learn discussion on some of the most common valuation methods being used, the typical investment terms to expect from […]
Lunch & Learn: The Payer Perspective
Join Cambia Grove for The Payer Perspective with Nic Anderson, Managing Partner at LDD Partners, and Jeremy Porter, Operating Partner at Waveny Ventures, to discuss incorporating health economics and a market access strategy into your business plan. This Lunch & Learn will be taking place virtually. Learn more and register here. […]